KALA (KALA) Stock Price & Analysis
KALA (KALA) rose 0.00% to USD 0.63 as of July 25, 2026 at 04:19 UTC, according to Nexqual real-time market data.
KALA last closed at USD 0.63; the session ranged USD 0.59–0.7 on volume of 122,542 shares. Market capitalization is —, with a 52-week range of USD 0.59–1,030 (NCM). Source: Nexqual, July 25, 2026 at 04:19 UTC.
Key Statistics (as of July 25, 2026 at 04:19 UTC)
| Price | USD 0.63 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.63 |
| Open | USD 0.63 |
| Day Range | USD 0.59 – 0.7 |
| 52-Week Range | USD 0.59 – 1,030 |
| Volume | 122,542 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (KALA)
Nexqual's technical model rates KALA "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:19 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.28 (neutral) |
| vs SMA50 | Below (USD 2.07) |
| MACD | -0.55 (negative) |
From KALA's Latest SEC 10-K Filing (filed 2026-04-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | USD 3.24 | ▼ 2.7% |
| PALI | Palisade Bio, Inc. | USD 1.95 | ▲ 2.63% |
| NERV | Minerva Neurosciences, Inc | USD 4.04 | ▼ 8.8% |
| KPTI | Karyopharm Therapeutics Inc. | USD 7.41 | ▲ 3.2% |
| ARDX | Ardelyx, Inc. | USD 5.03 | ▼ 0.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:19 UTC. This page is informational and not investment advice.